Pletal and diabetes mellitus inadequate control Patient Reports February 13, 2012
Pletal Side Effects Report #5920080-1
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on Oct 03, 2008. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with cerebral infarction and was treated with Pletal. After drug was administered, patient experienced the following side effects: diabetes mellitus inadequate control, pancreatic carcinoma. Pletal dosage: unknown. During the same period patient was treated with GLUFAST, MOHRUS TAPE, MEVAN, AMARYL, MAGNESIUM OXIDE. Patient recovered.
Pletal Side Effects Report #6022813-5
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on Dec 18, 2008. Male patient, 74 years of age, weighting 108.0 lb, was diagnosed with cerebral infarction, hyperlipidaemia, type 2 diabetes mellitus, constipation
and was treated with Pletal. After drug was administered, patient experienced the following side effects: blood glucose increased, blood pressure decreased, blood pressure systolic decreased, body temperature decreased, brain oedema, diabetes mellitus inadequate control, dysarthria, gastritis, liver abscess. Pletal dosage: unknown. During the same period patient was treated with PRAVASTATIN, AMARYL, MAGNESIUM OXIDE, GLUFAST, KETOPROFEN. Patient was hospitalized. Patient died on 12/13/2008.Pletal Side Effects Report #5803918-8
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2008. Female patient, 61 years of age, was diagnosed with cerebral infarction, hypertension and was treated with Pletal. After drug was administered, patient experienced the following side effects: blood glucose increased, blood potassium increased, diabetes mellitus inadequate control, glycosylated haemoglobin increased. Pletal dosage: 100 MG, BID, ORAL. During the same period patient was treated with CETAPRIL, GLIMICRON, SAIREI, AMLODIN OD, MEVALOTIN, TRICOR, KINEDAK. Patient recovered.
Pletal Side Effects Report #5836083-1
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on July 25, 2008. Female patient, 61 years of age, weighting 125.7 lb, was diagnosed with cerebral infarction and was treated with Pletal. After drug was administered, patient experienced the following side effects: blood potassium increased, cerebral infarction, diabetes mellitus inadequate control, diabetic nephropathy, disease recurrence. Pletal dosage: 100 MG, BID, ORAL. During the same period patient was treated with CETAPRIL, GLIMICRON, SAIREI, AMLODIN OD, MEVALOTIN, TRICOR, KINEDAK. Patient recovered.
Pletal Side Effects Report #5839349-4
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on July 25, 2008. Female patient, 61 years of age, weighting 125.7 lb, was diagnosed with cerebral infarction and was treated with Pletal. After drug was administered, patient experienced the following side effects: blood potassium increased, diabetes mellitus inadequate control, diabetic retinopathy, hyperphagia. Pletal dosage: 100 MG, BID ORAL. During the same period patient was treated with CETAPRIL, GLIMICRON, SAIREI, AMLODIN OD, MEVALOTIN, TRICOR, KINEDAK. Patient recovered.
Pletal Side Effects Report #5874994-1
Pletal side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2008. Female patient, 61 years of age, was diagnosed with cerebral infarction and was treated with Pletal. After drug was administered, patient experienced the following side effects: blood potassium increased, diabetes mellitus inadequate control, glycosylated haemoglobin increased. Pletal dosage: unknown. During the same period patient was treated with CETAPRIL, GLIMICRON, SAIREI, AMLODIN OD, MEVALOTIN, TRICOR, KINEDAK. Patient recovered.
Pletal and diabetes mellitus inadequate control 